PRESS RELEASE published on 02/20/2023 at 13:36, 3 years ago Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
PRESS RELEASE published on 02/20/2023 at 13:34, 3 years ago Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
PRESS RELEASE published on 02/17/2023 at 15:28, 3 years ago Form 8.3 - The Vanguard Group, Inc.: Home REIT plc
PRESS RELEASE published on 02/17/2023 at 14:37, 3 years ago Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
PRESS RELEASE published on 02/17/2023 at 14:35, 3 years ago Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
PRESS RELEASE published on 02/17/2023 at 14:33, 3 years ago Form 8.3 - The Vanguard Group, Inc.: Devro plc
PRESS RELEASE published on 02/17/2023 at 14:31, 3 years ago Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
PRESS RELEASE published on 02/17/2023 at 14:29, 3 years ago Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
PRESS RELEASE published on 02/16/2023 at 14:03, 3 years ago Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
PRESS RELEASE published on 02/15/2023 at 14:13, 3 years ago Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Published on 03/13/2026 at 00:30, 7 hours 18 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures
Published on 03/12/2026 at 22:55, 8 hours 53 minutes ago Faraday Copper Reports 2025 Financial Results
Published on 03/12/2026 at 22:15, 9 hours 33 minutes ago Avidian Gold Announces the Appointment of a New Director
Published on 03/12/2026 at 22:00, 9 hours 48 minutes ago Onco-Innovations Announces Closing of Private Placement
Published on 03/12/2026 at 21:30, 10 hours 18 minutes ago Loop Industries to Attend the 38th Annual ROTH Conference, March 22-24, 2026
Published on 03/13/2026 at 07:00, 48 minutes ago Medacta Group SA: Medacta Group reports record results in Full Year 2025 and upgrades mid-term guidance
Published on 03/13/2026 at 06:30, 1 hour 18 minutes ago OMRON Charts Data-Driven Path to 2030 for European Business
Published on 03/13/2026 at 07:30, 18 minutes ago BIOPHYTIS PRESENTS ITS DEVELOPMENT PROGRAMS IN OBESITY AND SARCOPENIA AT THE ICFSR CONFERENCE
Published on 03/12/2026 at 18:00, 13 hours 48 minutes ago NEW OR RENEWED AGREEMENTS BETWEEN EURAZEO AND CERTAIN FAMILY SHAREHOLDERS
Published on 03/12/2026 at 15:06, 16 hours 42 minutes ago FIERA MILANO: THE BOARD OF DIRECTORS APPROVES THE CONSOLIDATED RESULTS AS OF 31 DECEMBER 2025
Published on 03/12/2026 at 10:55, 20 hours 53 minutes ago Statement of transactions in own shares on March 9th, 2026
Published on 03/12/2026 at 07:30, 1 day ago Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics